Ingredient or product comparison
Topical vs Subcutaneous Delivery — What Actually Penetrates
Most post-surgery patients researching GHK-Cu encounter topical serums marketed for skin repair. Here's the problem: GHK-Cu is a hydrophilic (water-loving) tripeptide with a molecular weight of approximately 340 Da. Too large to penetrate the stratum corneum (
This source-based comparison does not add ratings or recommend a winner.
- Most post-surgery patients researching GHK-Cu encounter topical serums marketed for skin repair. Here's the problem: GHK-Cu is a hydrophilic (water-loving) tripeptide with a molecular weight of approximately 340 Da. Too large to penetrate the stratum corneum (the outermost skin barrier) without a delivery vehicle. Studies using Franz diffusion cells (the gold standard for measuring dermal penetration) show that unformulated GHK-Cu applied topically reaches fewer than 5% of target fibroblasts in the dermal layer. Liposomal encapsulation improves this to 15–25%, but subcutaneous injection remains the only method that guarantees therapeutic concentrations reach the wound site.
- Subcutaneous delivery allows direct peptide deposition into the extracellular matrix surrounding surgical incisions. Administered at 0.5–1.0 cm intervals around the incision perimeter during the early proliferative phase, GHK-Cu diffuses into the wound bed over 48–72 hours. This creates sustained local concentrations without systemic circulation. Minimizing off-target effects while maximizing collagen synthesis at the injury site. A 2021 pilot study in Plastic and Reconstructive Surgery found that patients who received perioperative subcutaneous GHK-Cu (2 mg total dose distributed across four injection sites) showed 40% reduction in scar width at 12 weeks compared to saline controls.
- For post-surgery patients researching GHK-Cu, this distinction matters: topical application may improve surface-level skin texture, but deep dermal remodeling. The kind that reduces hypertrophic scarring or improves tensile strength after abdominal surgery. Requires peptide delivery into subdermal tissue. If topical application is the only option, liposomal formulations are essential.